203 related articles for article (PubMed ID: 28408714)
1. Association Between Peritoneal Glucose Exposure and Peritonitis in Peritoneal Dialysis Patients: The balANZ Trial.
Nataatmadja M; Cho Y; Pascoe EM; Darssan D; Hawley CM; Johnson DW;
Perit Dial Int; 2017; 37(4):407-413. PubMed ID: 28408714
[TBL] [Abstract][Full Text] [Related]
2. The effects of biocompatible compared with standard peritoneal dialysis solutions on peritonitis microbiology, treatment, and outcomes: the balANZ trial.
Johnson DW; Brown FG; Clarke M; Boudville N; Elias TJ; Foo MW; Jones B; Kulkarni H; Langham R; Ranganathan D; Schollum J; Suranyi MG; Tan SH; Voss D;
Perit Dial Int; 2012; 32(5):497-506. PubMed ID: 22991015
[TBL] [Abstract][Full Text] [Related]
3. The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the balANZ trial.
Johnson DW; Brown FG; Clarke M; Boudville N; Elias TJ; Foo MW; Jones B; Kulkarni H; Langham R; Ranganathan D; Schollum J; Suranyi MG; Tan SH; Voss D;
Nephrol Dial Transplant; 2012 Dec; 27(12):4445-53. PubMed ID: 22859794
[TBL] [Abstract][Full Text] [Related]
4. Associations Between Peritoneal Glucose Exposure, Glucose Degradation Product Exposure, and Peritoneal Membrane Transport Characteristics in Peritoneal Dialysis Patients: Secondary Analysis of the
Nataatmadja MS; Johnson DW; Pascoe EM; Darssan D; Hawley CM; Cho Y;
Perit Dial Int; 2018; 38(5):349-355. PubMed ID: 30087174
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of neutral-pH, low-glucose degradation product peritoneal dialysis solutions compared with standard solutions: a secondary analysis of the balANZ Trial.
Howard K; Hayes A; Cho Y; Cass A; Clarke M; Johnson DW
Am J Kidney Dis; 2015 May; 65(5):773-9. PubMed ID: 25746151
[TBL] [Abstract][Full Text] [Related]
6. Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients.
Cho Y; Johnson DW; Vesey DA; Hawley CM; Pascoe EM; Clarke M; Topley N;
BMC Nephrol; 2014 Jan; 15():8. PubMed ID: 24410736
[TBL] [Abstract][Full Text] [Related]
7. Effects of Conversion to a Bicarbonate/Lactate-Buffered, Neutral-pH, Low-GDP PD Regimen in Prevalent PD: A 2-Year Randomized Clinical Trial.
Farhat K; Douma CE; Ferrantelli E; Ter Wee PM; Beelen RHJ; van Ittersum FJ
Perit Dial Int; 2017; 37(3):273-282. PubMed ID: 28348100
[TBL] [Abstract][Full Text] [Related]
8. Biocompatible dialysis fluids for peritoneal dialysis.
Cho Y; Johnson DW; Craig JC; Strippoli GF; Badve SV; Wiggins KJ
Cochrane Database Syst Rev; 2014 Mar; (3):CD007554. PubMed ID: 24671928
[TBL] [Abstract][Full Text] [Related]
9. Higher Dialysate Matrix Metalloproteinase-2 Levels Are Associated with Peritoneal Membrane Dysfunction.
Cho Y; Johnson DW; Vesey DA; Hawley CM; Pascoe EM; Clarke M; Topley N;
Perit Dial Int; 2016; 36(1):16-25. PubMed ID: 25292407
[TBL] [Abstract][Full Text] [Related]
10. Glucose Exposure in Peritoneal Dialysis Is a Significant Factor Predicting Peritonitis.
Uiterwijk H; Franssen CFM; Kuipers J; Westerhuis R; Nauta FL
Am J Nephrol; 2020; 51(3):237-243. PubMed ID: 32069459
[TBL] [Abstract][Full Text] [Related]
11. Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes.
Johnson DW; Brown FG; Clarke M; Boudville N; Elias TJ; Foo MW; Jones B; Kulkarni H; Langham R; Ranganathan D; Schollum J; Suranyi M; Tan SH; Voss D;
J Am Soc Nephrol; 2012 Jun; 23(6):1097-107. PubMed ID: 22440906
[TBL] [Abstract][Full Text] [Related]
12. Rationale and design of the balANZ trial: a randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal function.
Johnson DW; Clarke M; Wilson V; Woods F; Brown FG
BMC Nephrol; 2010 Sep; 11():25. PubMed ID: 20843375
[TBL] [Abstract][Full Text] [Related]
13. The Association Between Glucose Exposure and the Risk of Peritonitis in Peritoneal Dialysis Patients.
van Diepen AT; van Esch S; Struijk DG; Krediet RT
Perit Dial Int; 2016 9-10; 36(5):533-9. PubMed ID: 27044793
[TBL] [Abstract][Full Text] [Related]
14. Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: a randomized controlled 1-year follow-up study.
Park SH; Do JY; Kim YH; Lee HY; Kim BS; Shin SK; Kim HC; Chang YK; Yang JO; Chung HC; Kim CD; Lee WK; Kim JY; Kim YL
Nephrol Dial Transplant; 2012 Mar; 27(3):1191-9. PubMed ID: 21862454
[TBL] [Abstract][Full Text] [Related]
15. Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance).
Lee HY; Park HC; Seo BJ; Do JY; Yun SR; Song HY; Kim YH; Kim YL; Kim DJ; Kim YS; Ahn C; Kim MJ; Shin SK
Perit Dial Int; 2005; 25(3):248-55. PubMed ID: 15981773
[TBL] [Abstract][Full Text] [Related]
16. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
[TBL] [Abstract][Full Text] [Related]
17. The Trio Trial - A Randomized Controlled Clinical Trial Evaluating the Effect of a Biocompatible Peritoneal Dialysis Solution on Residual Renal Function.
Sikaneta T; Wu G; Abdolell M; Ng A; Mahdavi S; Svendrovski A; Tu T; Mercer T; Tong M; Oreopoulos D; Tam P
Perit Dial Int; 2016 9-10; 36(5):526-32. PubMed ID: 27282852
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Residual Renal Function Decline in Peritoneal Dialysis Patients: The
Htay H; Cho Y; Pascoe EM; Darssan D; Hawley C; Johnson DW;
Perit Dial Int; 2017; 37(3):283-289. PubMed ID: 27935537
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to assess impact on biomarkers of peritoneal health.
Vychytil A; Herzog R; Probst P; Ribitsch W; Lhotta K; Machold-Fabrizii V; Wiesholzer M; Kaufmann M; Salmhofer H; Windpessl M; Rosenkranz AR; Oberbauer R; König F; Kratochwill K; Aufricht C
Kidney Int; 2018 Dec; 94(6):1227-1237. PubMed ID: 30360960
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of dialysate cell counts in peritonitis complicating peritoneal dialysis.
Chow KM; Szeto CC; Cheung KK; Leung CB; Wong SS; Law MC; Ho YW; Li PK
Clin J Am Soc Nephrol; 2006 Jul; 1(4):768-73. PubMed ID: 17699285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
